News

Open Letter for NPUK Community [Bloomsbury Genetic Therapies Limited]

Cyclo Therapeutics – Phase 3 Study of NPC now enrolling in UK

Azafaros Receives FDA's IND Clearance and Fast Track Designation for Lead Asset AZ-3102

IB1001-301 Recruitment Complete

IntraBio Ltd: Nov 301 NPC UK Recruitment Update

IntraBio Ltd. is pleased to share that the Phase III pivotal trial with N-acetyl-L-leucine (IB1001-301) clinical trial has enrolled over 70% of the target number of patients in the second month of recruitment...